2.97 USD
▲-0.01+1.37%
盘后 2.94 +0.34%
2026-08-03
市值
$35.53M
市盈率
—
EPS
-5.22
股息率
—
52 周区间
2.49 – 27.69
成交量
113.63K
Beta
2.79
目标价
—
52W 低 2.4952W 高 27.69
价格走势
公司简介
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder. It is also developing IHL-675A, an oral fixe...